This inventor holds 1 USPTO granted patent. Top assignees: Mitsubishi Rayon Company, Limited, The Japanese Red Cross Society. Active years: 1993.
Company Filing History:
1 out of 1,357 
1 out of 9 Years Active: 1993
Title: Inventor Takeji Ohtani: A Pioneer in Immunoglobulin G Production
Introduction: Takeji Ohtani, a brilliant inventor from Tokyo, Japan, has made significant contributions to the field of biochemistry through his innovative work on immunoglobulin G (IgG). His research not only advances scientific understanding but also has practical applications in medicine, particularly in intravenous therapies.
Latest Patents: Takeji Ohtani holds a notable patent for the invention titled "Immunoglobulin G and process for the production thereof." This patent details a method of producing crude immunoglobulin G isolated from human blood plasma. By employing conventional techniques, such as the tricalcium phosphate adsorption method, Ohtani describes how to effectively remove aggregates from the IgG to ensure they are not detectable by gel filtration analysis. The process further includes filtering the resulting solution through a porous polyolefin membrane, allowing for the production of an aqueous solution of IgG that possesses reduced anticomplementary activity. This innovative solution is deemed suitable for intravenous injection, underscoring its medical relevance.
Career Highlights: Ohtani has had a distinguished career, working with esteemed organizations such as Mitsubishi Rayon Company, Limited and The Japanese Red Cross Society. His professional experiences have not only provided him with a platform to showcase his inventions, but they have also contributed to advancements in clinical applications of his work.
Collaborations: Throughout his career, Takeji Ohtani has collaborated with prominent professionals in his field, including colleagues Tohru Suzuki and Hiroyuki Ikeda. These collaborations have likely fostered a creative environment that enhances innovation, allowing for the detailed exploration of immunoglobulin research.
Conclusion: Takeji Ohtani's contributions to the field of immunoglobulin research through his patented process exemplify the fusion of innovation and practical application. His work not only benefits the scientific community but also has the potential to positively impact patient care through improved therapeutic options in medical settings. Ohtani's dedication to advancing science continues to inspire future generations of inventors and researchers.